| A targetable LIFR− NF-κB− LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis F Yao, Y Deng, Y Zhao, Y Mei, Y Zhang, X Liu, C Martinez, X Su, ... Nature communications 12 (1), 7333, 2021 | 131 | 2021 |
| SET1A-mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis L Fang, H Teng, Y Wang, G Liao, L Weng, Y Li, X Wang, J Jin, C Jiao, ... Cancer cell 34 (1), 103-118. e9, 2018 | 125 | 2018 |
| p38 inhibition provides anti–DNA virus immunity by regulation of USP21 phosphorylation and STING activation Y Chen, L Wang, J Jin, Y Luan, C Chen, Y Li, H Chu, X Wang, G Liao, ... Journal of Experimental Medicine 214 (4), 991-1010, 2017 | 95 | 2017 |
| Ubiquitination of Rheb governs growth factor-induced mTORC1 activation LU Deng, L Chen, L Zhao, Y Xu, X Peng, X Wang, L Ding, J Jin, H Teng, ... Cell research 29 (2), 136-150, 2019 | 94 | 2019 |
| AMPK promotes SPOP-mediated NANOG degradation to regulate prostate cancer cell stemness X Wang, J Jin, F Wan, L Zhao, H Chu, C Chen, G Liao, J Liu, Y Yu, H Teng, ... Developmental cell 48 (3), 345-360. e7, 2019 | 77 | 2019 |
| Identification of glutaminyl cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis Z Wu, L Weng, T Zhang, H Tian, L Fang, H Teng, W Zhang, J Gao, Y Hao, ... Cell research 29 (6), 502-505, 2019 | 54 | 2019 |
| Expression of SHH signaling pathway components in the developing human lung M Zhang, H Wang, H Teng, J Shi, Y Zhang Histochemistry and cell biology 134, 327-335, 2010 | 49 | 2010 |
| SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells Y Yan, H Teng, Q Hang, L Kondiparthi, G Lei, A Horbath, X Liu, C Mao, ... Nature communications 14 (1), 3673, 2023 | 40 | 2023 |
| Challenges and strategies in ascribing functions to long noncoding RNAs Y Zhao, H Teng, F Yao, S Yap, Y Sun, L Ma Cancers 12 (6), 1458, 2020 | 40 | 2020 |
| Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity L Fang, Y Hao, H Yu, X Gu, Q Peng, H Zhuo, Y Li, Z Liu, J Wang, Y Chen, ... Cancer Cell 41 (6), 1118-1133. e12, 2023 | 29 | 2023 |
| Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance Q Hang, L Zeng, L Wang, L Nie, F Yao, H Teng, Y Deng, S Yap, Y Sun, ... Nature communications 12 (1), 4033, 2021 | 15 | 2021 |
| Disruption of β-arrestins blocks glucocorticoid receptor and severely retards lung and liver development in mice M Zhang, H Teng, J Shi, Y Zhang Mechanisms of Development 128 (7-10), 368-375, 2011 | 15 | 2011 |
| USP7 substrates identified by proteomics analysis reveal the specificity of USP7 L Nie, C Wang, X Liu, H Teng, S Li, M Huang, X Feng, G Pei, Q Hang, ... Genes & Development 36 (17-18), 1016-1030, 2022 | 12 | 2022 |
| Progress of animal organs development regulated by let-7 microRNA H Wang, HQ Teng, JP Shi, YD Zhang, MF Zhang Chinese Bulletin of Life Sciences 23 (4), 364-368, 2011 | 4 | 2011 |
| Extracellular Vesicles (EVs) in Tumor Diagnosis and Therapy M Tan, Y Ge, X Wang, Y Wang, Y Liu, F He, H Teng Technology in cancer research & treatment 22, 15330338231171463, 2023 | 3 | 2023 |
| DePARylation is critical for S phase progression and cell survival L Nie, C Wang, M Huang, X Liu, X Feng, M Tang, S Li, Q Hang, H Teng, ... Elife 12, RP89303, 2024 | 1 | 2024 |
| CRISPR–Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames C Zheng, Y Wei, P Zhang, K Lin, D He, H Teng, G Manyam, Z Zhang, ... Nature Structural & Molecular Biology 30 (12), 1878-1892, 2023 | 1 | 2023 |
| LIFR recruits HGF-producing neutrophils to promote liver injury repair and regeneration Y Deng, Z Zhao, M Sheldon, Y Zhao, H Teng, C Martinez, J Zhang, C Lin, ... bioRxiv, 2023.03. 18.533289, 2023 | 1 | 2023 |
| Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis Y Zhao, J Ning, H Teng, Y Deng, M Sheldon, L Shi, C Martinez, J Zhang, ... Nature communications 15 (1), 2384, 2024 | | 2024 |
| ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer Y Mei, Q Hang, H Teng, F Yao, MK Chen, MC Hung, Y Sun, L Ma Genes & Diseases 10 (5), 1739, 2023 | | 2023 |
